Skip to main content
. 2019 May 30;18(2):1415–1423. doi: 10.3892/ol.2019.10410

Table I.

EZH2 and HDAC1/2 expression in PTCL.

Neoplasm EZH2 HDAC1 HDAC2
PTCL 53/82 50/82 47/82
PTCL-NOS 29/43 24/43 25/43
AICL 6/10 5/10 6/10
NK/TCL 7/14 8/14 8/14
ALCL 11/15 13/15 8/15

EZH2, enhancer of zeste homolog 2; HDAC, histone deacetylase; PTCL, peripheral T cell lymphoma; PTCL-NOS, PTCL not otherwise specified; AICL, angioimmunoblastic T-cell lymphoma; ALCL; anaplastic large cell lymphoma; NK/TCL, natural killer/T-cell.